Abstract 5234: A phase I study of HMPL-689, a small molecule selective inhibitor of phosphoinositide 3-kinase-delta, inpatients with relapsed or refractory lymphoma
Lawrence, Tunde, Khullar, Alisha, Yang, Weiss, Hahka-Kemppinen, Marjo, Kania, Marek, Su, Weigou
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 5239: A phase I study of HMPL-523, a small molecule, selective inhibitor of spleen tyrosine kinase, inpatients with relapsed or refractory lymphoma
Lawrence, Tunde, Khullar, Alisha, Yang, Weiss, Hahka-Kemppinen, Marjo, Kania, Marek, Su, Weigou
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article